ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma-Reference-Cited by-同舟云学术

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

Published:2018-01-02 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Han Shujun,Ren Yibo,He Wangxiao,Liu Huadong,Zhi Zhe,Zhu Xinliang,Yang Tielin^ORCID,Rong Yu,Ma Bohan,Purwin Timothy J.,Ouyang Zhenlin,Li Caixia,Wang Xun,Wang Xueqiang,Yang Huizi,Zheng Yan,Aplin Andrew E.,Liu Jiankang,Shao Yongping

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-02354-x.pdf

Reference39 articles.

1. Flaherty, K. T. et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. New Engl. J. Med. 367, 1694–1703 (2012).

2. Sosman, J. A. et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. New Engl. J. Med. 366, 707–714 (2012).

3. Flaherty, K. T. et al. Inhibition of mutated, activated BRAF in metastatic melanoma. New Engl. J. Med. 363, 809–819 (2010).

4. Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New Engl. J. Med. 364, 2507–2516 (2011).

5. Aplin, A. E., Kaplan, F. M. & Shao, Y. Mechanisms of resistance to RAF inhibitors in melanoma. J. Invest. Dermatol. 131, 1817–1820 (2011).

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An extra-glycolytic function for hexokinase 2 as an RNA-binding protein regulatingSOX10mRNA translation in melanoma;2024-08-13

2. Clinical Correlation of Transcription Factor SOX3 in Cancer: Unveiling Its Role in Tumorigenesis;Genes;2024-06-13

3. Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition;Frontiers in Oncology;2024-05-16

4. HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs;Cancer Drug Resistance;2024-04-29

5. SOX on tumors, a comfort or a constraint?;Cell Death Discovery;2024-02-09